Last checked at 11 Mar 2021 05:59
TOP NEWS: GSK, partner Vir chase US emergency use for virus antibody
TOP NEWS: GSK, partner Vir chase US emergency use for virus antibody
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,583.50
Bid:
1,582.50
Ask:
1,583.00
Change:
0.00 (0.00%)
Spread:
0.50 (0.032%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
1,583.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.11 Mar 2021 02:38
UPDATE 3-Vir, GSK to seek emergency use clearance for COVID-19 antibody therapy
(Adds comments from chief executive George Scangos)By Carl O'DonnellMarch 10 (Reuters) - Vir Biotechnology and Britain's GSK plan to seek emergency use authorization for their experimental COVID-19 antibody therapy after interim data from a study ...
Read more9 Mar 2021 16:27
UK says it has not blocked any COVID-19 vaccine exports
LONDON, March 9 (Reuters) - Britain has not blocked the export of COVID-19 vaccines, a UK government spokesman said on Tuesday.“The UK government has not blocked the export of a single COVID-19 vaccine. Any references to a UK export ban or any re...
Read more9 Mar 2021 16:05
Nearly 22.6 million Britons have received first COVID-19 vaccine dose
LONDON, March 9 (Reuters) - A total of 22,592,528 Britons have received the first dose of a coronavirus vaccine, according to official data released on Tuesday which also showed a further 5,766 cases and 231 deaths within 28 days of a positive tes...
Read more8 Mar 2021 06:05
J&J, ViiV Healthcare drug combo provides long-term HIV suppression
J&J, ViiV Healthcare drug combo provides long-term HIV suppression
Read more5 Mar 2021 15:10
EXECUTIVE CHANGES: On The Beach adds Justine Greening to board
EXECUTIVE CHANGES: On The Beach adds Justine Greening to board
Read more4 Mar 2021 13:25
Thursday broker round-up
(Sharecast News) - Weir: Deutsche Bank downgrades to hold with a target price of 2,000p.
Read more4 Mar 2021 13:11
UPDATE 2-Novartis joins CureVac's vaccine contractor line-up
* Trial read-out expected early in second quarter* Other partners include Bayer, GSK, Fareva, Rentschler* Novartis site to come online in summer of 2021* Novartis to make up to 50 mln doses this year (Adds update on timing of trial read-out, product...
Read more4 Mar 2021 13:11
UPDATE 1-Novartis deal bolsters CureVac's vaccine contractor line-up
* Other partners include Bayer, GSK, Fareva, Rentschler* Novartis site to come on-stream in summer of 2021* Novartis to make up to 50 mln doses this yr, more next year (Adds details on partners)By Ludwig BurgerFRANKFURT, March 4 (Reuters) - German ...
Read more2 Mar 2021 16:00
Nearly 20.5 million Britons have received first COVID-19 vaccine dose
LONDON, March 2 (Reuters) - A total of 20,478,619 Britons have been given the first dose of a COVID-19 vaccine, according to official data released on Tuesday which also showed a further 6,391 cases and 343 deaths within 28 days of a positive test...
Read more2 Mar 2021 09:40
BROKER RATINGS: Prudential, Pennon and Royal Mail get upgrades
BROKER RATINGS: Prudential, Pennon and Royal Mail get upgrades
Read more26 Feb 2021 14:19
European Regulator Recommends GlaxoSmithKline's Dostarlimab Approval
European Regulator Recommends GlaxoSmithKline's Dostarlimab Approval
Read more25 Feb 2021 19:21
GSK Covid-19 monoclonal treatment shows potential benefit for older patients
(Sharecast News) - A phase two clinical study on GlaxoSmithKline's monoclonal antibody treatment against Covid-19 revealed a "potentially important" benefit in reducing respiratory failure in patients aged 70 or older.
Read more25 Feb 2021 12:23
GlaxoSmithKline To Amend Covid-19 Treatment Study To Confirm Findings
GlaxoSmithKline To Amend Covid-19 Treatment Study To Confirm Findings
Read more25 Feb 2021 12:00
GSK narrows focus on elderly in trial to treat pneumonia from COVID-19
By Ludwig BurgerFRANKFURT, Feb 25 (Reuters) - GlaxoSmithKline will extend a trial testing an experimental rheumatoid arthritis drug on patients suffering from pneumonia related to COVID-19 to focus on the elderly as it seeks to firm up encouraging...
Read more